Elicitation of protective immune responses using a bivalent H5N1 VLP vaccine
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1743-422X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Elicitation of protective immune responses using a bivalent H5N1 VLP vaccine ; volume:5 ; number:1 ; day:28 ; month:10 ; year:2008 ; pages:1-9 ; date:12.2008
Virology journal ; 5, Heft 1 (28.10.2008), 1-9, 12.2008
- Urheber
-
Crevar, Corey J.
- Beteiligte Personen und Organisationen
-
Ross, Ted M.
SpringerLink (Online service)
- DOI
-
10.1186/1743-422X-5-131
- URN
-
urn:nbn:de:1111-2016043045931
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Crevar, Corey J.
- Ross, Ted M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Duration of protective immunity after a single vaccination with a live attenuated bivalent bluetongue vaccine
Systemic prime mucosal boost significantly increases protective efficacy of bivalent RSV influenza viral vectored vaccine
Lack of allele-specific efficacy of a bivalent AMA1 malaria vaccine
A computational approach to design a multiepitope vaccine against H5N1 virus
Human Papillomavirus Genotype Distribution Patterns in Zimbabwe: Is the Bivalent Vaccine Sufficient?
Differential long-term bivalent HPV vaccine cross-protection by variants in the Costa Rica HPV vaccine trial
Modular Hydrogel Vaccine for Programmable and Coordinate Elicitation of Cancer Immunotherapy
Vaccine elicitation of HIV broadly neutralizing antibodies from engineered B cells
Bivalent mRNA vaccine effectiveness against SARS-CoV-2 variants of concern
Cross-protective immunity against influenza A/H1N1 virus challenge in mice immunized with recombinant vaccine expressing HA gene of influenza A/H5N1 virus
Preclinical immunogenicity assessment of a cell-based inactivated whole-virion H5N1 influenza vaccine
Recombinant measles viruses : use as bivalent vaccine and modulation of their membrane fusion activity
Duration of protective immunity after a single vaccination with a live attenuated bivalent bluetongue vaccine
Systemic prime mucosal boost significantly increases protective efficacy of bivalent RSV influenza viral vectored vaccine
Lack of allele-specific efficacy of a bivalent AMA1 malaria vaccine
A computational approach to design a multiepitope vaccine against H5N1 virus
Human Papillomavirus Genotype Distribution Patterns in Zimbabwe: Is the Bivalent Vaccine Sufficient?
Differential long-term bivalent HPV vaccine cross-protection by variants in the Costa Rica HPV vaccine trial
Modular Hydrogel Vaccine for Programmable and Coordinate Elicitation of Cancer Immunotherapy
Vaccine elicitation of HIV broadly neutralizing antibodies from engineered B cells
Bivalent mRNA vaccine effectiveness against SARS-CoV-2 variants of concern
Cross-protective immunity against influenza A/H1N1 virus challenge in mice immunized with recombinant vaccine expressing HA gene of influenza A/H5N1 virus
Preclinical immunogenicity assessment of a cell-based inactivated whole-virion H5N1 influenza vaccine
Recombinant measles viruses : use as bivalent vaccine and modulation of their membrane fusion activity
Duration of protective immunity after a single vaccination with a live attenuated bivalent bluetongue vaccine
Systemic prime mucosal boost significantly increases protective efficacy of bivalent RSV influenza viral vectored vaccine
Lack of allele-specific efficacy of a bivalent AMA1 malaria vaccine
A computational approach to design a multiepitope vaccine against H5N1 virus
Human Papillomavirus Genotype Distribution Patterns in Zimbabwe: Is the Bivalent Vaccine Sufficient?
Differential long-term bivalent HPV vaccine cross-protection by variants in the Costa Rica HPV vaccine trial
Modular Hydrogel Vaccine for Programmable and Coordinate Elicitation of Cancer Immunotherapy
Vaccine elicitation of HIV broadly neutralizing antibodies from engineered B cells
Bivalent mRNA vaccine effectiveness against SARS-CoV-2 variants of concern
Cross-protective immunity against influenza A/H1N1 virus challenge in mice immunized with recombinant vaccine expressing HA gene of influenza A/H5N1 virus
Preclinical immunogenicity assessment of a cell-based inactivated whole-virion H5N1 influenza vaccine